1131324 - Genomic Health Inc - SEC Form 4 Insider Trading Screener

Services - Health Services - Medical Laboratories - GHDX (1131324)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S13-0-0+3+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2017-11-07
GHDXCole G BradleyCOOM - OptEx$17.33+5,00039,935+14%+$86,650
D
2017-11-07
GHDXCole G BradleyCOOS - Sale+OE$31.47-5,00039,935-11%-$157,330
DM
2017-11-01
GHDXVaughn James JChief Commercial OfficerM - OptEx$17.33+4,83127,620+21%+$83,721
DM
2017-11-01
GHDXVaughn James JChief Commercial OfficerS - Sale+OE$32.57-6,99627,620-20%-$227,829
D
2017-10-10
GHDXCole G BradleyCOOM - OptEx$17.33+5,00039,935+14%+$86,650
D
2017-10-10
GHDXCole G BradleyCOOS - Sale+OE$31.93-5,00039,935-11%-$159,637
2017-10-01
GHDXFuchs Henry JDirA - Grant$32.09+3115,226+6%+$9,980
2017-10-01
GHDXCohen Fred EDirA - Grant$32.09+31172,5810%+$9,980
2017-10-01
GHDXGraham Ginger LDirA - Grant$32.09+3119,447+3%+$9,980
2017-10-01
GHDXBaker Bros. Advisors LPDir, 10%A - Grant$32.09+3,732504,010+1%+$119,760
D
2017-09-14
GHDXPopovits Kimberly JPres, CEOM - OptEx$17.33+5,000307,567+2%+$86,650
D
2017-09-14
GHDXPopovits Kimberly JPres, CEOS - Sale+OE$31.00-5,000307,567-2%-$154,989
D
2017-09-12
GHDXCole G BradleyCOOM - OptEx$17.33+5,00039,935+14%+$86,650
D
2017-09-12
GHDXCole G BradleyCOOS - Sale+OE$31.86-5,00039,935-11%-$159,288
D
2017-08-14
GHDXPopovits Kimberly JPres, CEOM - OptEx$17.33+5,000307,567+2%+$86,650
D
2017-08-14
GHDXPopovits Kimberly JPres, CEOS - Sale+OE$30.22-5,000307,567-2%-$151,111
D
2017-08-08
GHDXVaughn James JChief Commercial OfficerM - OptEx$23.31+6,50029,785+28%+$151,515
D
2017-08-08
GHDXVaughn James JChief Commercial OfficerS - Sale+OE$30.59-8,00029,785-21%-$244,724
D
2017-08-08
GHDXCole G BradleyCOOM - OptEx$17.33+5,00039,935+14%+$86,650
D
2017-08-08
GHDXCole G BradleyCOOS - Sale+OE$30.57-5,00039,935-11%-$152,846
2017-07-19
GHDXFebbo Phillip G.Chief Medical OfficerS - Sale$33.57-3,17417,800-15%-$106,538
D
2017-07-11
GHDXCole G BradleyCOOM - OptEx$17.33+5,00039,935+14%+$86,650
D
2017-07-11
GHDXCole G BradleyCOOS - Sale+OE$32.53-5,00039,935-11%-$162,667
DM
2017-07-03
GHDXPopovits Kimberly JPres, CEOM - OptEx$17.33+5,000307,567+2%+$86,650
DM
2017-07-03
GHDXPopovits Kimberly JPres, CEOS - Sale+OE$32.59-5,000307,567-2%-$162,941
2017-07-01
GHDXFuchs Henry JDirA - Grant$32.55+3074,915+7%+$9,993
2017-07-01
GHDXCohen Fred EDirA - Grant$32.55+30772,2700%+$9,993
2017-07-01
GHDXGraham Ginger LDirA - Grant$32.55+3079,136+3%+$9,993
2017-07-01
GHDXBaker Bros. Advisors LPDir, 10%A - Grant$32.55+3,684503,388+1%+$119,914
D
2017-06-23
GHDXShak StevenChief Scientific OfficerM - OptEx$23.31+5,000331,924+2%+$116,550
D
2017-06-23
GHDXShak StevenChief Scientific OfficerS - Sale+OE$33.27-5,000331,924-1%-$166,371
D
2017-06-13
GHDXCole G BradleyCOOM - OptEx$17.33+5,00039,935+14%+$86,650
D
2017-06-13
GHDXCole G BradleyCOOS - Sale+OE$31.67-5,00039,935-11%-$158,342
D
2017-06-05
GHDXPopovits Kimberly JPres, CEOG - Gift$0.00-100307,5670%-$0
D
2017-06-05
GHDXPopovits Kimberly JPres, CEOM - OptEx$17.33+5,000307,567+2%+$86,650
D
2017-06-05
GHDXPopovits Kimberly JPres, CEOS - Sale+OE$32.32-5,000307,567-2%-$161,582
D
2017-05-31
GHDXBaker Bros. Advisors LPDir, 10%M - OptEx$18.13+49,500502,774+11%+$897,435
D
2017-05-23
GHDXShak StevenChief Scientific OfficerM - OptEx$23.31+5,000331,103+2%+$116,550
D
2017-05-23
GHDXShak StevenChief Scientific OfficerS - Sale+OE$29.40-5,000331,103-1%-$146,981
D
2017-05-19
GHDXCohen Fred EDirM - OptEx$14.37+8,25071,963+13%+$118,553
D
2017-05-19
GHDXCohen Fred EDirS - Sale+OE$29.54-8,25071,963-10%-$243,745
D
2017-05-18
GHDXCohen Fred EDirM - OptEx$18.05+16,50071,963+30%+$297,743
D
2017-05-18
GHDXCohen Fred EDirS - Sale+OE$29.88-16,50071,963-19%-$493,040
D
2017-05-16
GHDXCohen Fred EDirM - OptEx$18.13+8,25071,963+13%+$149,573
D
2017-05-16
GHDXCohen Fred EDirS - Sale+OE$30.68-8,25071,963-10%-$253,102
2017-05-15
GHDXRadford Jason W.GCF - Tax$30.81-1,25324,902-5%-$38,605
D
2017-05-03
GHDXPopovits Kimberly JPres, CEOM - OptEx$17.33+5,000306,846+2%+$86,650-1-9
D
2017-05-03
GHDXPopovits Kimberly JPres, CEOS - Sale+OE$31.77-5,000306,846-2%-$158,849-1-9
D
2017-04-24
GHDXShak StevenChief Scientific OfficerM - OptEx$23.31+5,000331,103+2%+$116,55000
D
2017-04-24
GHDXShak StevenChief Scientific OfficerS - Sale+OE$31.46-5,000331,103-1%-$157,32300
DM
2017-03-20
GHDXPopovits Kimberly JPres, CEOG - Gift$0.00-1,364506,3330%-$0+1+1+7
D
2017-04-03
GHDXPopovits Kimberly JPres, CEOM - OptEx$20.80+5,000506,333+1%+$103,992+1+1+7
D
2017-04-03
GHDXPopovits Kimberly JPres, CEOS - Sale+OE$31.30-5,000506,333-1%-$156,507+1+1+7
2017-04-01
GHDXBaker Bros. Advisors LPDir, 10%A - Grant$31.49+3,804494,524+1%+$119,788-1+2+3
2017-04-01
GHDXFuchs Henry JDirA - Grant$31.49+3174,608+7%+$9,982-1+2+3
2017-04-01
GHDXCohen Fred EDirA - Grant$31.49+31771,9630%+$9,982-1+2+3
2017-04-01
GHDXGraham Ginger LDirA - Grant$31.49+3178,829+4%+$9,982-1+2+3
D
2017-03-23
GHDXShak StevenChief Scientific OfficerM - OptEx$23.31+5,000331,103+2%+$116,550+1+10
D
2017-03-23
GHDXShak StevenChief Scientific OfficerS - Sale+OE$31.26-5,000331,103-1%-$156,295+1+10
2017-03-20
GHDXLeber LauraChief Communication OfficerS - Sale$31.88-3,07214,627-17%-$97,9410+2+2
D
2017-03-08
GHDXCole G BradleyCOOM - OptEx$23.31+5,71039,528+17%+$133,100-10-2
D
2017-03-08
GHDXCole G BradleyCOOS - Sale+OE$31.55-5,71039,528-13%-$180,134-10-2
DM
2017-03-03
GHDXPopovits Kimberly JPres, CEOM - OptEx$23.31+5,000308,210+2%+$116,550+10-1
DM
2017-03-03
GHDXPopovits Kimberly JPres, CEOS - Sale+OE$31.09-5,000308,210-2%-$155,455+10-1
D
2017-02-23
GHDXShak StevenChief Scientific OfficerM - OptEx$23.31+5,000331,103+2%+$116,550-1+2+4
D
2017-02-23
GHDXShak StevenChief Scientific OfficerS - Sale+OE$29.36-5,000331,103-1%-$146,815-1+2+4
2017-02-15
GHDXVaughn James JChief Commercial OfficerF - Tax$31.12-3,41730,502-10%-$106,337-1+3+10
2017-02-15
GHDXShak StevenChief Scientific OfficerF - Tax$31.12-2,884331,103-1%-$89,750-1+3+10
2017-02-15
GHDXRadford Jason W.GCF - Tax$31.12-77126,155-3%-$23,994-1+3+10
2017-02-15
GHDXPopovits Kimberly JPres, CEOF - Tax$31.12-4,982308,210-2%-$155,040-1+3+10
2017-02-15
GHDXPla FredericChief Bus, Prod Dev OfficerF - Tax$31.12-2,88231,700-8%-$89,688-1+3+10
2017-02-15
GHDXMcEachron KimChief People OfficerF - Tax$31.12-2,19727,620-7%-$68,371-1+3+10
2017-02-15
GHDXLeber LauraChief Communication OfficerF - Tax$31.12-2,07817,699-11%-$64,667-1+3+10
2017-02-15
GHDXFebbo Phillip G.Chief Medical OfficerF - Tax$31.12-1,91020,644-8%-$59,439-1+3+10
2017-02-16
GHDXFebbo Phillip G.Chief Medical OfficerS - Sale$30.09-2,49520,644-11%-$75,064-1+3+10
D
2017-02-15
GHDXCole G BradleyCOOF - Tax$31.12-3,29439,728-8%-$102,509-1+3+10
D
2017-02-15
GHDXCole G BradleyCOOM - OptEx$23.31+5,00039,728+14%+$116,550-1+3+10
D
2017-02-15
GHDXCole G BradleyCOOS - Sale+OE$29.00-5,00039,728-11%-$145,000-1+3+10
D
2017-01-31
GHDXVaughn James JChief Commercial OfficerA - Grant$0.00+7,84033,919+30%+$0+10+12
D
2017-01-31
GHDXShak StevenChief Scientific OfficerA - Grant$0.00+6,780333,987+2%+$0+10+12
D
2017-01-31
GHDXRadford Jason W.GCA - Grant$0.00+11,44026,926+74%+$0+10+12
D
2017-01-31
GHDXPopovits Kimberly JPres, CEOA - Grant$0.00+27,760317,354+10%+$0+10+12
D
2017-01-31
GHDXPla FredericChief Bus, Prod Dev OfficerA - Grant$0.00+8,14034,582+31%+$0+10+12
D
2017-01-31
GHDXMcEachron KimChief People OfficerA - Grant$0.00+6,22029,817+26%+$0+10+12
D
2017-01-31
GHDXLeber LauraChief Communication OfficerA - Grant$0.00+5,29019,777+37%+$0+10+12
D
2017-01-31
GHDXFebbo Phillip G.Chief Medical OfficerA - Grant$0.00+11,44025,049+84%+$0+10+12
D
2017-01-31
GHDXCole G BradleyCOOA - Grant$0.00+8,14044,022+23%+$0+10+12
D
2017-01-23
GHDXShak StevenChief Scientific OfficerM - OptEx$23.31+5,000327,207+2%+$116,550-1+2+9
D
2017-01-23
GHDXShak StevenChief Scientific OfficerS - Sale+OE$27.28-5,000327,207-2%-$136,387-1+2+9
D
2017-01-10
GHDXCole G BradleyCOOM - OptEx$23.31+5,00035,882+16%+$116,550+1-6-3
D
2017-01-10
GHDXCole G BradleyCOOS - Sale+OE$29.22-5,00035,882-12%-$146,087+1-6-3
2017-01-01
GHDXGraham Ginger LDirA - Grant$29.39+3408,512+4%+$9,993-10-7
2017-01-01
GHDXFuchs Henry JDirA - Grant$29.39+3404,291+9%+$9,993-10-7
2017-01-01
GHDXCohen Fred EDirA - Grant$29.39+34071,6460%+$9,993-10-7
2017-01-01
GHDXBaker FelixDir, 10%A - Grant$29.39+4,080493,890+1%+$119,911-10-7
2016-05-15
GHDXRadford Jason W.GCF - Tax$27.28-1,42014,554-9%-$38,738-1-2-10
M
2015-08-15
GHDXFebbo Phillip G.Chief Medical OfficerF - Tax$25.93-2,13113,241-14%-$55,247-1-2-10
D
2016-12-06
GHDXCole G BradleyCOOM - OptEx$23.31+5,00035,882+16%+$116,550-10-6
D
2016-12-06
GHDXCole G BradleyCOOS - Sale+OE$30.61-5,00035,882-12%-$153,030-10-6
D
2016-12-05
GHDXPopovits Kimberly JPres, CEOM - OptEx$23.31+5,000289,594+2%+$116,550-10-5

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top